FDA Commissioner nominee Scott Gottlieb told Senators at his April 5 confirmation hearing that he views devices, and drug-delivery devices, as a possible solution to the nation's opioid epidemic.
While the physician and venture capitalist spent much of hearing explaining to Senate HELP panel Democrats how his many medical-product industry ties would not influence his leadership of the agency and his willingness to challenge the Trump administration when necessary (Also see "Gottlieb Confirmation: He's Willing To Disagree With Trump, Price" - Medtech